Greenland Mines Ltd
Greenland Mines Ltd (Nasdaq: GRML) develops medicines for chronic diseases and, following its March 2026 acquisition of Greenland Mines Corp., also operates in the development and mining of critical and precious minerals. Its pharmaceutical programs include licensed generic and biosimilar cancer therapies and a… From the company’s description.
In fiscal 2025, Greenland Mines Ltd reported a net loss of $10.55M. Operations used $5.89M in cash.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What Greenland Mines Ltd does
In the company’s own words
Greenland Mines Ltd (Nasdaq: GRML) develops medicines for chronic diseases and, following its March 2026 acquisition of Greenland Mines Corp., also operates in the development and mining of critical and precious minerals. Its pharmaceutical programs include licensed generic and biosimilar cancer therapies and a proprietary gene-therapy platform designed to produce the Klotho protein in the body for neurodegenerative and age-related disorders. The lead preclinical gene-therapy candidates target Alzheimer’s disease and amyotrophic lateral sclerosis (ALS); the company also holds rights to biosimilar antibodies and market authorizations for anti-cancer drugs in Germany. Its oncology portfolio includes drugs used in FOLFOX and FOLFIRI regimens and for metastatic lung cancer, while licensed biosimilar candidates include rituximab, trastuzumab, bevacizumab and cetuximab. The company also plans to develop a Klotho isoform assay that could serve as a commercial diagnostic. Its research and development programs are supported by licenses and research collaborations with universities and life-sciences organizations. Greenland Mines Ltd was formerly known as Klotho Neurosciences, Inc.
Company details
- Sector
- Health Care
- Industry (SIC)
- Biological Products
- Headquarters
- OMAHA, NE
- Fiscal year end
- December
- CIK
- 1907223
- SIC
- 2836
Financial performance, year by year
Fiscal 2022–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns Greenland Mines Ltd — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · Greenland Mines Ltd’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do Greenland Mines Ltd and its peers compare on margins and cash generation over ten years?”
- “Where did five years of Greenland Mines Ltd's earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in Greenland Mines Ltd's last four quarterly filings that the numbers alone won't show?”